Abstract
There is no known pathophysiological link and, indeed, very little in the literature written about menopause and restless legs syndrome (RLS). Because the cellular mechanisms explaining the causality of RLS are unknown, much literature has focused on numerous associations in order to discover the etiology and pathophysiology of the disorder in men and women. Some widely held generalizations occur in the literature, including characterizions of the disorder as commonly occurring in middle to late age and with higher prevalence in women. Following this line of logic, one would naturally posit a relationship between RLS and menopause. However, as is discussed in this chapter, these widely held generalizations need to be reexamined in the context of recent epidemiological population- and patient-based data so that the information gathered from the clinical and basic sciences can best be integrated and possible mechanisms underlying RLS discovered, including what role, if any, changes associated with menopause may play in the disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kavanagh, D., S. Siddiqui, and C.C. Geddes, Restless legs syndrome in patients on dialysis. Am J Kidney Dis, 2004;43(5):763–771.
Allen, R.P., D. Picchiettti, W.A. Hening, C. Trenkwalder, A.S. Walters, and J. Montplaisir, Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med, 2003;4(2):101–119.
Berger, K., J. Luedemann, C. Trenkwalder, U. John, and C. Kessler, Sex and the risk of restless legs syndrome in the general population. Arch Intern Med, 2004;164(2):196–202.
Schapira, A.H., Restless legs syndrome: an update on treatment options. Drugs, 2004;64(2):149–158.
Hornyak, M. and C. Trenkwalder, Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res, 2004;56(5):543–548.
Turjanski, N., A.J. Lees, and D.J. Brooks, Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology, 1999;52(5):932–937.
Trenkwalder, C. and W. Paulus, Why do restless legs occur at rest?-pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2). Clin Neurophysiol, 2004;115(9):1975–1988.
Garcia-Borreguero, D., O. Larrosa, J.J. Granizo, Y. de la Llave, and W.A. Hening, Circadian effects of dopaminergic treatment in restless legs syndrome. Sleep Med, 2004;5(4):413–420.
Chesson, A.L., Jr., M. Wise, D. Davila, et al., Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep, 1999;22(7):961–968.
Walters, A.S., K. Hickey, J. Maltzman, et al., A questionnaire study of 138 patients with restless legs syndrome: the ‘Night-Walkers’ survey. Neurology, 1996;46(1):92–95.
Garcia-Borreguero, D., P. Odin, and C. Schwarz, Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand, 2004;109(5):303–317.
Phillips, B., T. Young, L. Finn, K. Asher, W.A. Hening, and C. Purvis, Epidemiology of restless legs symptoms in adults. Arch Intern Med, 2000;160(14):2137–2141.
Winkelmann, J., T.C. Wetter, V. Collado-Seidel, et al., Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep, 2000;23(5):597–602.
Rothdach, A.J., C. Trenkwalder, J. Haberstock, U. Keil, and K. Berger, Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology, 2000;54(5):1064–1068.
Allen, R.P., A.S. Walters, J. Montplaisir, et al., Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med, 2005;165(11):1286–1292.
Montplaisir, J., S. Boucher, G. Poirier, G. Lavigne, O. Lapierre, and P. Lesperance, Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord, 1997;12(1):61–65.
Ondo, W. and J. Jankovic, Restless legs syndrome: clinicoetiologic correlates. Neurology, 1996;47(6):1435–1441.
Trenkwalder, C., Restless-legs syndrome in primary care: counting patients in Idaho. Lancet Neurol, 2004;3(2):83.
Ondo, W.G., K.D. Vuong, and Q. Wang, Restless legs syndrome in monozygotic twins: clinical correlates. Neurology, 2000;55(9):1404–1406.
Tison, F., A. Crochard, D. Leger, S. Bouee, E. Lainey, and A. El Hasnaoui, Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology, 2005;65(2):239–246.
Nichols, D.A., R.P. Allen, J.H. Grauke, et al., Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med, 2003;163(19):2323–2329.
Polo-Kantola, P. and R. Erkkola, Sleep and the menopause. J Br Menopause Soc, 2004;10(4):145–150.
Chaudhuri, K.R., A. Forbes, D. Grosset, et al., Diagnosing restless legs syndrome (RLS) in primar care. Curr Med Res Opin, 2004;20(11):1785–1795.
Sukegawa, T., M. Itoga, H. Seno, et al., Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin Neurosci, 2003;57(3):265–270.
Stiasny-Kolster, K., C. Trenkwalder, W. Fogel, et al., Restless legs syndrome-new insights into clinical characteristics, pathophysiology, and treatment options. J Neurol, 2004. 251(Suppl 6):VI/39-VI/43.
Moline, M., L. Broch, and R. Zak, Sleep problems across the life cycle in women. Curr Treat Options Neurol, 2004;6(4):319–330.
Garcia-Borreguero, D., C. Serrano, O. Larrosa, and J.J. Granizo, Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep, 2004;27(4):669–673.
Michaud, M., J.P. Soucy, A. Chabli, G. Lavigne, and J. Montplaisir, SPECT imaging of striatal pre-and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol, 2002;249(2):164–1670.
Erikson, K.M., B.C. Jones, and J.L. Beard, Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr, 2000;130(11):2831–2837.
Connor, J.R., P.J. Boyer, S.L. Menzies, et al., Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology, 2003;61(3):304–309.
Lee, K.A., M.E. Zaffke, and K. Baratte-Beebe, Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med, 2001;10(4):335–341.
Earley, C.J., D. Heckler, and R.P. Allen, Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med, 2005;6(4):301–305.
Moyer, P., Compromised brain iron abnormalities linked to early-onset restless legs syndrome. Neurology Today, 2005;489.
Manconi, M., V. Govoni, A. De Vito, et al., Restless legs syndrome and pregnancy. Neurology, 2004;63(6):1065–1069.
Rijsman, R., A.K. Neven, W. Graffelman, B. Kemp, and A. de Weerd, Epidemiology of restless legs in The Netherlands. Eur J Neurol, 2004;11(9):607–611.
Polo-Kantola, P., M. Dumont, J. Paquet, A. Desautels, M.L. Fantini, and J. Montplaisir, Estrogen replacement therapy and nocturnal periodic limb movements: a randomized controlled trial. Obstet Gynecol, 2001;97(4):548–554.
Manconi, M., M. Dumont, B. Selmaoui, J. Paquet, M.L. Fantini, and J. Montplaisir, Pregnancy as a risk factor for restless legs syndrome. Sleep Med, 2004;5(3):305–308.
Eichling, P. and J. Sahni, Menopause related sleep disorders. J Clin Sleep Med, 2005;1(3):291–300.
Jourdain, S., M. Morissette, N. Morin, and T. Di Paolo, Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) is substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. J Neuroendocrinol, 2005;17(8):509–517.
Genazzani, A.R., F. Bernardi, N. Pluchino, et al., Endocrinology of menopausal transition and its brain implications. CNS Spectr, 2005;10(6):449–457.
Michaud, M., E. Rauhala, R. Erkkola, K. Irjala, and O. Polo, Circadian variation of the effects of immobility on symptoms of restless legs syndrome. Sleep, 2005;28(7):843–846.
Michaud, M., V. Govoni, A. De Vito, et al., Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol, 2004;55(3):372–380.
Okatani, Y., N. Morioka, and A. Wakatsuki, Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res, 2000;28(2):111–118.
Zeitzer, J.M., J.E. Daniels, J.F. Duffy, Do plasma melatonin concentrations decline with age? Am J Med, 1999;107(5):432–436.
Fernandez, B., J.L. Malde, A. Montero, and D. Acuna, Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. J Steroid Biochem, 1990;35(2):257–262.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Collins, N.S. (2006). Restless Legs Syndrome and Menopause. In: Attarian, H.P. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-115-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-115-4_17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-592-7
Online ISBN: 978-1-59745-115-4
eBook Packages: MedicineMedicine (R0)